The related genes, including CCL2, CRYAB, HSBP1, IFIT3, PSMB10, RBX1, and SPARC, with potential promoting or inhibitory roles in NAFLD pathogenesis, were subsequently identified and represented a crucial step in developing prospective clinical diagnostic method for this condition. This evidence concerns the gene RBX1 and metabolic dysfunction-associated steatotic liver disease.